ABVC BioPharma, Inc. Deferred Revenue Recognized
ABVC BioPharma, Inc. (ECOC) reported Deferred Revenue Recognized of $296.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2024-11-14
- ABVC BioPharma, Inc. contract with customer, liability, revenue recognized for the quarter ending 2024-09-30 was $296.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month |
|---|---|
| 2024-09-30 | $296.00K 10-Q · filed 2024-11-14 |